These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 33809961)

  • 21. TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro.
    Duan QQ; Wang H; Su WM; Gu XJ; Shen XF; Jiang Z; Ren YL; Cao B; Li GB; Wang Y; Chen YP
    BMC Med; 2024 Mar; 22(1):96. PubMed ID: 38443977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type 2 Diabetes Mellitus and Amyotrophic Lateral Sclerosis: Genetic Overlap, Causality, and Mediation.
    Chen H; Zhang J; Wang T; Zhang S; Lai Q; Huang S; Zeng P
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4497-e4508. PubMed ID: 34171091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Harnessing Transcriptomic Signals for Amyotrophic Lateral Sclerosis to Identify Novel Drugs and Enhance Risk Prediction.
    Pain O; Jones A; Al Khleifat A; Agarwal D; Hramyka D; Karoui H; Kubica J; Llewellyn DJ; Ranson JM; Yao Z; Iacoangeli A; Al-Chalabi A
    medRxiv; 2023 Jan; ():. PubMed ID: 36747854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Causal relationship and shared genes between air pollutants and amyotrophic lateral sclerosis: A large-scale genetic analysis.
    Li Z; Wen J; Wu W; Dai Z; Liang X; Zhang N; Cheng Q; Zhang H
    CNS Neurosci Ther; 2024 Jul; 30(7):e14812. PubMed ID: 38970158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second-generation Irish genome-wide association study for amyotrophic lateral sclerosis.
    McLaughlin RL; Kenna KP; Vajda A; Bede P; Elamin M; Cronin S; Donaghy CG; Bradley DG; Hardiman O
    Neurobiol Aging; 2015 Feb; 36(2):1221.e7-13. PubMed ID: 25442119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy.
    Morello G; Cavallaro S
    Future Med Chem; 2015; 7(10):1335-59. PubMed ID: 26144267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Transcriptome-Wide Analysis of Psoriasis: Identifying the Potential Causal Genes and Drug Candidates.
    Jeong Y; Song J; Lee Y; Choi E; Won Y; Kim B; Jang W
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative multi-omic analysis identifies new drivers and pathways in molecularly distinct subtypes of ALS.
    Morello G; Guarnaccia M; Spampinato AG; Salomone S; D'Agata V; Conforti FL; Aronica E; Cavallaro S
    Sci Rep; 2019 Jul; 9(1):9968. PubMed ID: 31292500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients.
    Saucier D; Wajnberg G; Roy J; Beauregard AP; Chacko S; Crapoulet N; Fournier S; Ghosh A; Lewis SM; Marrero A; O'Connell C; Ouellette RJ; Morin PJ
    Brain Res; 2019 Apr; 1708():100-108. PubMed ID: 30552897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis.
    Bandres-Ciga S; Noyce AJ; Hemani G; Nicolas A; Calvo A; Mora G; ; ; Tienari PJ; Stone DJ; Nalls MA; Singleton AB; Chiò A; Traynor BJ
    Ann Neurol; 2019 Apr; 85(4):470-481. PubMed ID: 30723964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis.
    Matamala JM; Arias-Carrasco R; Sanchez C; Uhrig M; Bargsted L; Matus S; Maracaja-Coutinho V; Abarzua S; van Zundert B; Verdugo R; Manque P; Hetz C
    Neurobiol Aging; 2018 Apr; 64():123-138. PubMed ID: 29458840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study.
    van Rheenen W; Diekstra FP; Harschnitz O; Westeneng HJ; van Eijk KR; Saris CGJ; Groen EJN; van Es MA; Blauw HM; van Vught PWJ; Veldink JH; van den Berg LH
    PLoS One; 2018; 13(6):e0198874. PubMed ID: 29939990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shared genetic links between amyotrophic lateral sclerosis and obesity-related traits: a genome-wide association study.
    Li C; Ou R; Wei Q; Shang H
    Neurobiol Aging; 2021 Jun; 102():211.e1-211.e9. PubMed ID: 33640203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptomics and Metabolomics in Amyotrophic Lateral Sclerosis.
    Krokidis MG
    Adv Exp Med Biol; 2020; 1195():205-212. PubMed ID: 32468479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
    Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
    JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing a novel immune infiltration-associated mitophagy prediction model for amyotrophic lateral sclerosis using bioinformatics strategies.
    Du R; Chen P; Li M; Zhu Y; He Z; Huang X
    Front Immunol; 2024; 15():1360527. PubMed ID: 38601155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients.
    Imamura K; Izumi Y; Banno H; Uozumi R; Morita S; Egawa N; Ayaki T; Nagai M; Nishiyama K; Watanabe Y; Hanajima R; Oki R; Fujita K; Takahashi N; Ikeda T; Shimizu A; Morinaga A; Hirohashi T; Fujii Y; Takahashi R; Inoue H
    BMJ Open; 2019 Dec; 9(12):e033131. PubMed ID: 31796494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of multiple novel susceptibility genes associated with autoimmune thyroid disease.
    Liu X; Miao Y; Liu C; Lu W; Feng Q; Zhang Q
    Front Immunol; 2023; 14():1161311. PubMed ID: 37197658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Personal genome analysis in amyotrophic lateral sclerosis].
    Tanaka F; Sone J; Atsuta N; Nakamura R; Doi H; Koyano S; Sobue G
    Brain Nerve; 2013 Mar; 65(3):257-65. PubMed ID: 23475517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis.
    Fiscon G; Conte F; Amadio S; Volonté C; Paci P
    Neurotherapeutics; 2021 Jul; 18(3):1678-1691. PubMed ID: 33987813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.